Preoperative ketorolac increases bleeding after tonsillectomy in children

Can J Anaesth. 1996 Jun;43(6):560-3. doi: 10.1007/BF03011766.

Abstract

Purpose: To compare the incidence of vomiting following codeine or ketorolac for tonsillectomy in children.

Methods: We had planned to enrol 240 patients, aged 2-12 yr undergoing elective tonsillectomy into a randomized, single-blind study in University Children's Hospital. The study was terminated, after 64 patients because interim analysis of the data by a blinded non-study scientist concluded that the patients were at undue risk of excessive perioperative bleeding. After induction of anaesthesia by inhalation with N2O/halothane or with propofol 2.5-3.5 mg.kg-1 i.v., the children were administered 150 micrograms.kg-1 ondansetron and 50 micrograms.kg-1 midazolam. Maintenance of anaesthesia was with N2O and halothane in O2. Subjects were administered either 1.5 mg.kg-1 codeine im or 1 mg.kg-1 ketorolac i.v. before the commencement of surgery. Intraoperative blood loss was measured with a Baxter Medi-Vac Universal Critical Measurement Unit. Postoperative management of vomiting and pain was standardized. Vomiting was recorded for 24 hr after anaesthesia. Data were compared with ANOVA, Chi-Square analysis and Fisher Exact Test.

Results: Thirty-five subjects received ketorolac. Demographic data were similar. The incidence of vomiting during the postoperative period was 31% in the codeine-group and 40% in the ketorolac-group. Intraoperative blood losses was 1.3 +/- 0.8 ml.kg-1 after codeine and 2.2 +/- 1.9 ml.kg-1 after ketorolac (mean +/- SD) P < 0.05. Five ketorolac-treated patients had bleeding which led to unscheduled admission to hospital, P < 0.05, Exact Test.

Conclusion: Preoperative ketorolac increases perioperative bleeding among children undergoing tonsillectomy without beneficial effects.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Analgesics, Non-Narcotic / administration & dosage
  • Analgesics, Non-Narcotic / adverse effects*
  • Analgesics, Non-Narcotic / therapeutic use
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / therapeutic use
  • Analysis of Variance
  • Anesthesia, Inhalation
  • Anesthetics, Inhalation / administration & dosage
  • Anesthetics, Intravenous / administration & dosage
  • Antiemetics / administration & dosage
  • Antiemetics / adverse effects*
  • Antiemetics / therapeutic use
  • Blood Loss, Surgical
  • Child
  • Child, Preschool
  • Codeine / administration & dosage
  • Codeine / therapeutic use
  • Elective Surgical Procedures
  • Halothane / administration & dosage
  • Humans
  • Ketorolac
  • Midazolam / administration & dosage
  • Nitrous Oxide / administration & dosage
  • Ondansetron / administration & dosage
  • Ondansetron / therapeutic use
  • Oral Hemorrhage / etiology*
  • Postoperative Hemorrhage / etiology*
  • Premedication*
  • Propofol / administration & dosage
  • Single-Blind Method
  • Tolmetin / administration & dosage
  • Tolmetin / adverse effects
  • Tolmetin / analogs & derivatives*
  • Tolmetin / therapeutic use
  • Tonsillectomy*
  • Vomiting / prevention & control

Substances

  • Analgesics, Non-Narcotic
  • Analgesics, Opioid
  • Anesthetics, Inhalation
  • Anesthetics, Intravenous
  • Antiemetics
  • Ondansetron
  • Tolmetin
  • Nitrous Oxide
  • Midazolam
  • Halothane
  • Codeine
  • Propofol
  • Ketorolac